|
Søren is Professor of Human Oncology and Professor of Medical Physics at the University of Wisconsin Medical School in Madison, Wisconsin, USA. He is also Director of Research and Education in the Department of Human Oncology at the University of Wisconsin Comprehensive Cancer Center, Qualifications: MSc in Mathematics and Physics (1981), PhD in Medical Imaging (1986) and DSc in Clinical Radiobiology (1994), all from the University of Aarhus, Denmark. He worked in Aarhus from 1981 to 1997 except for periods as a Visiting Scientist (1987-1988) and a Visiting Professor (1995) at the MD Anderson Cancer Center. From 1998 to 2004 he was Head of the Human Cancer Biology and Informatics Group in the Gray Laboratory in Northwood, Middlesex, UK. Main research interests: translational radiation oncology including work on predictive and prognostic factors, biological optimization of radiotherapy and combined modalities, evidence-based oncology. More recently his main interest has been the incorporation of data from genomics, proteomics and functional imaging into novel strategies for radiation therapy. Søren has published more than 240 scientific papers, serves on the editorial boards of six international cancer journals, is former chairman of the Radiobiology Committee of the ESTRO (1997-2002) and current member of the Translational Research Advisory Committee of the EORTC. He is a frequent teacher in national and international courses including the annual FECS/AACR/ASCO workshop in Flims. His scientific work has been recognized by a total of 10 awards and named lectureships including the 2003 Klaas Breuer Gold Medal from the ESTRO. |
 |
Dr. Fernie is Vice President, Research at Toronto Rehab. He is a professor in the Department of Surgery at the University of Toronto with cross-appointments that include the Institute of Biomaterials and Biomedical Engineering, the Graduate Department of Rehabilitation Science and the Departments of Mechanical and Industrial Engineering, Physical Therapy and Occupational Therapy. Dr. Fernie was the Director of the Centre for Studies in Aging at Sunnybrook & Women’s College Health Sciences Centre until he joined Toronto Rehab in September of 2003. A mechanical engineer by background, Dr Fernie has approximately 100 peer-reviewed journal papers and book chapters, and 16 families of patents. Dr. Fernie has a doctorate in Bioengineering from the University of Strathclyde. The recipient of the 2002 Jonas Salk Award, Dr. Fernie has played active roles in launching three spin-off companies and has six innovative products on the market. His committee roles include the advisory boards of the CIHR Institute of Aging, the Medical and Assistive Devices Consortium of Ontario and Western New York, and the Veteran’s Administration Research Center in Atlanta. He is an executive member and team leader of the very successful Ontario Rehabilitation Technology Consortium. In 2001 Dr Fernie organised the first International Conference on Technology and Aging (ICTA), which was held in Canada. Much of Dr Fernie’s work is aimed at increasing awareness of opportunities to improve the quality of living for seniors and people with disabilities through research into assistive technology. |
 |
Dr. William’s particular interests are in radiation dosimetry and radiotherapy equipment development: he worked on electron beam dosimetry necessary for the widespread introduction of electron therapy in the UK and was involved in the design and commissioning of the fi rst widely available multi-leaf collimator for 3D conformal radiotherapy. He was involved in the development and implementation of the technology for IMRT and linear accelerator based image guided therapy. In 1999 he became Director of North Western Medical Physics, a department of 175 scientists and technologists providing a regional service around Manchester. Professionally he has served on numerous national and international working parties and started a 2 year term as President of the Institute of Physics in Engineering in Medicine in 2003. |
 |
Dr. Easty is Director of the Department of Medical Engineering at the University Health Network (Toronto General Hospital, Toronto Western Hospital and Princess Margaret Hospital) and at Mount Sinai Hospital, Toronto. He holds a BSc (Hons), and D.Ic and PhD degrees from the UK. He is a Certifi ed Clinical Engineer, and an Assistant Professor at the Institute of Biomaterials & Biomedical Engineering, and in the Department of Electrical Engineering, University of Toronto, Canada. Tony co-authored the Standards of Practice for Clinical Engineering in Canada, the fi rst standard of this kind in the world, which are now used as the basis for peer reviews of departments in Canada and elsewhere. He is also co-author of a CD-ROM entitled “Aspects of Electrosurgery”, which provides guidance to surgeons, nurses, biomedical engineers and technologists, and others on the safe use of electrosurgery in the operating room with over 20 000 copies distributed. |
 |
Professor in Medical Radiation Physics at Lund University and Head of the Department of Radiation Physics at Malmö University Hospital. Soren is an eminent radiology physicist with extensive professional interests and research areas, e.g.: Optimisation in medical x-ray imaging, radiation dose to patients from radiopharmaceuticals, radioanalytical methods for use in vivo; body composition studies, radiation protection among populations, patients, personnel, plankton and plants, real time in vivo luminescence dosimetry in radiotherapy and diagnostic radiology using Al2O3:C, accelerator mass spectrometry for biomedicine and radiation protection, protons for radiotherapy, digital mammography and others. Soren is also a member of many committees, for example: member of the research board of the Swedish Cancer Society and chairman of its committee on clinical oncology, with special reference to radiology, 1994-2000, Member of Committee 3 (Radiation in Medicine) of the International Commission on Radiological Protection, 1985-present, Chairman of its Task Group for “Dose to Patients from Radio pharmaceuticals”, 1987-present, Member of the Swedish National Council for Nuclear Waste, 1988-present. He is an author of many papers, 2 patents and a supervisor to numerous postgraduate students. In 1992 he was awarded the Erna Ebelings Price from Svenska Läkaresällskapet for research in medical physics and biomedical engineering. In 2003 he was awarded Bo Lindell Mark of Honour from Nordic Society for Radiation Protection. |
 |
Dr. Gentles is vice president of BT Medical Technology Consulting (www.btmtc.com) working on equipment planning for hospitals, service reviews of Biomedical Engineering departments, and incident investigations in which medical equipment is involved. From 1972 - 2001 he was the Director of Biomedical Engineering at Sunnybrook & Women’s College Health Sciences Centre, a teaching hospital affi liated with the University of Toronto. Dr. Gentles is currently President of the Canadian Medical and Biological Engineering Society and President of the Clinical Engineering Society of Ontario. In collaboration with Dr. Tony Easty, Dr. Gentles co-authored the “Standard of Practice for Clinical Engineering in Canada”. He is now leading the implementation of a Peer Review process for Clinical Engineering Services in Canada, based on the Standard of Practice. |
 |
Professor Martin Ferguson-Pell was appointed to the ASPIRE Chair in Neuromuscular Restoration and Rehabilitation at University College London, Institute of Orthopaedics in 1995 where he founded the ASPIRE Centre for Disability Sciences (ASPIRE CDS). He is also Director of R&D at the Royal National Orthopaedic Hospital, Executive Chair of the North London Innovation Hub, Chair of the Foundation for Assistive Technology and Chair of the Scottish Executive’s Steering Committee reviewing Wheelchair and Special Seating Services. The ASPIRE CDS addresses functional improvements to disability in the widest sense. Prior to his UCL appointment, Martin was Founding Director of the Helen Hayes Hospital’s Center for Rehabilitation Technology, West Haverstraw, NY. Trained as a physicist, Martin completed a Ph.D. in Bioengineering at the University of Strathclyde in 1977. |
 |
Professor, Director of Experimental Radiation Oncology, St George Cancer
Care Centre, NSW. Barry Allen is currently director of the Centre for Experimental Radiation Oncology, St George Cancer Care Centre, NSW. He is also conjoint Professor at St George Clinical School, UNSW. His current fi elds of interest cover Boron Neutron Capture Therapy for Cancer physics, chemistry, biology, oncology, In Vivo Body Composition physical methods, clinical research, Protein Monitor, Experimental Radiation Oncology - dosimetry, Monte Carlo, microbeams, and also Targeted Alpha Therapy for cancer. He has published 273 scientifi c papers, book chapters and refereed conference papers, and obtained, since 1985, research grants totaling $4,000,000. Barry Allen was the President of the 2003 World Congress on Medical Physics and Biomedical Engineering, and currently he is President of Asia Oceania Federation of Medical Physics and also President Elect of the International Organization of Medical Physics. |
 |
Professor, Head of Medical Physics, University Hospital Birmingham NHS
Trust. Alun is Head of Medical Physics at the University Hospital Birmingham NHS Trust and also a Medical Physicist at Queen Elizabeth Hospital, Birmingham (UK). His major research interests have included bone morphology/dosimetry, a fi eld which underpins aspects of radiation protection and nuclear medicine, and in vivo neutron activation analysis and body composition, but he has dabbled in many other areas, mostly in applied radiation physics and protection, and has published quite extensively. His present arms-length interests include solid state detector responses, bone morphology (again), the oncogenicity of low LET radiation, indexing chemotherapy, effects of treatment delays on clinical outcome. He is currently the Editor-in-Chief of Physics in Medicine and Biology, is Chairman of the IPEM (UK) Fellowship Panel and holds the Honorary Chair of Radiological Physics at the University of Birmingham. |
 |
Associate Professor, Head of the Diagnostic Genetic Pathology service,
Flinders Medical Centre, SA. Pam Sykes obtained a PhD in Genetics at the University of Adelaide and pursued postdoctoral studies at the University of Oklahoma, USA. She is presently a Chief Medical Scientist and Head of the Diagnostic Genetic Pathology service at Flinders Medical Centre in South Australia, and has an academic appointment as Associate Professor at Flinders University. Her major research interests over the last 15 years have been in the area of residual disease in leukaemia and mutation research. The pKZ1 transgenic mouse was developed in her laboratory over the last 8 years as a mutation assay and has proven very sensitive for detection of mutations in response to very low doses of radiation and other DNA damaging agents. |
 |
Professor, SUNY Upstate Medical University, Syracuse, NY. Walter Huda studied Physics at Oxford University followed by a PhD in medical physics at the Royal Postgraduate Medical School (Hammersmith Hospital) at the University of London. From 1976 to 1981, Dr. Huda worked as a physicist at Amersham International, a commercial company specializing in radioactive products. In 1982, Dr. Huda moved to the Manitoba Cancer Treatment and Research Foundation in Winnipeg, Canada where he worked as a medical physicist in the fi elds of diagnostic imaging and medical radiation dosimetry. In 1990 he joined the University of Florida to become Director of Radiological Physics, and in 1997, Dr. Huda was appointed Professor of Radiology at the SUNY Upstate Medical University at Syracuse. His research interests are in medical imaging and radiation dosimetry. He has published one book, approximately 200 scientifi c papers, and is board certifi ed by the Canadian College of Physicists in Medicine and by the American Board of Medical Physics. |
 |
MSc, Principal Medical Scientist, Department of Nuclear Medicine, Royal
Adelaide Hospital, SA. Peter Collins is Principal Medical Scientist in the Department of Nuclear Medicine, Bone Densitometry and PET at the Royal Adelaide Hospital (RAH), and Radiation Safety Offi cer (RAH). His R/D interests include radiation dosimetry (Nuclear Medicine and Radiology), PET/CT and studies of gastrointestinal motility. Mr Collins runs a number of training courses in radiation safety for Radiologists, Radiographers and Medical Specialists. He is currently the President of the Australian and New Zealand Society of Nuclear Medicine and serves on a number of committees, including the working parties writing the National Codes of Practice for Nuclear Medicine and Radiology. |
 |
Associate Professor, Department of Nuclear Medicine, Royal North Shore
Hospital, NSW. Dale is currently principal physicist in the Department of Nuclear Medicine, Royal North Shore Hospital (RNSH), and Clinical Associate Professor in the Faculty of Medicine, University of Sydney. He has published over 70 papers in peer-reviewed journals and over 100 peer-reviewed abstracts. In May 2003 a major textbook Positron Emission Tomography: Basic Science & Clinical Practice was published with Dale as one of the principal editors. Dale’s interests are in the development of quantitative techniques using imaging of in vivo radionuclide tracers, SPECT and PET. He was instrumental in developing simultaneous emission/ transmission scanning on the gamma camera using the scanning radionuclide line source approach, which has now been implemented by nearly all manufacturers and he is currently developing an in-house SPECT/CT scanner. Dale has numerous clinical collaborations most notably in functional neuro-imaging and in respiratory medicine. |